SEARCH

SEARCH BY CITATION

References

  • 1
    Otterness D,Szumlanski C,Lennard L, et al. Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms. Clin Pharmacol Ther 1997; 62: 6073.
  • 2
    Lawson DH,Lovatt GE,Gurton GS, et al. Adverse effects of azathioprine. Adverse Drug React Acute Poisoning Rev 1984; 3: 161171.
  • 3
    Arnold JA,Ranson SA,Abdalla SH. Azathioprine-associated acute myeloid leukaemia with trilineage dysplasia and complex karyotype: A case report and review of the literature. Clin Lab Haematol 1999; 21: 289292.
  • 4
    Knipp S,Hildebrandt B,Richter J, et al. Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7. Haematologica 2005; 90: 691693.
  • 5
    Putzki N,Knipp S,Ramczykowski T, et al. Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis. Mult Scler 2006; 12: 363366.
  • 6
    Willerding-Mollman S,Wilkens L,Schlegelberger B,Kaiser U. Azathioprine-associated myelodysplastic syndrome with cytogenetic abnormalities. Dtsch Med Wochenschr 2004; 129: 12461248.
  • 7
    Au WY,Yuen MF,Lai KC, et al. Clonal marrow abnormalities after azathioprine and sulfasalazine exposure in Crohn's disease: A cautionary tale. Leuk Lymphoma 2002; 43: 16791681.
  • 8
    Then Bergh F,Niklas A,Strauss A, et al. Rapid progression of Myelodysplastic syndrome to acute myeloid leukemia on sequential azathioprine, IFN-beta and copolymer-1 in a patient with multiple sclerosis. Acta Haematol 2006; 116: 207210.
  • 9
    Thalhammer-Scherrer R,Wieselthaler G,Knoebl P, et al. Post-transplant acute myeloid leukemia: Mini-review and report of three cases. Leukemia 1999; 13: 321326.
  • 10
    Huebner G,Karthous M,Pethig K, et al. Myelodysplastic syndrome and acute myelogenous leukemia secondary to heart transplantation. Transplantation 2000; 70: 688690.
  • 11
    Depil S,Leleu X,Micol JB, et al. A case of refractory anemia with 17p- syndrome following azathioprine treatment for heart transplantation. Leukemia 2004; 18: 878.
  • 12
    Gorschluter M,Glasmacher A,Risse F, et al. Successful induction and consolidation therapy of acute myeloid leukaemia in a renal allograft recipient. Nephrol Dial Transplant 1997; 12: 593595.
  • 13
    Pikler GM,Say B,Stamper S. Cytogenetic findings in acute monocytic leukemia in a renal allograft recipient. Cancer Genet Cytogenet 1986; 20: 101107.
  • 14
    Crispino P,Pica R,Angelucci E, et al. Hematological malignancies in chronic inflammatory bowel diseases: Report of five cases and review of the literature. Int J Colorectal Dis 2007; 22: 553558.
  • 15
    Caspi O,Polliack A,Klar R,Ben-Yehuda D. The association of inflammatory bowel disease and leukemia—Coincidence or not? Leuk Lymphoma 1995; 17: 255262.
  • 16
    Halme L,von Knorring J,Elonen E. Development of acute myelocytic leukemia in patients with Crohn's disease. Dig Dis Sci 1990; 35: 15531556.
  • 17
    Mir Madjlessi SH,Farmer RG,Weick JK. Inflammatory bowel disease and leukemia. A report of seven cases of leukemia in ulcerative colitis and Crohn's disease and review of the literature. Dig Dis Sci 1986; 31: 10251031.
  • 18
    Dombret H,Marolleau JP. De novo acute myeloid leukemia in patients with Crohn's disease. Nouv Rev Fr Hematol 1995; 37: 193196.
  • 19
    Confavreux C,Saddier P,Grimaud J, et al. Risk of cancer from azathiorpine therapy in multiple sclerosis: A case-control study. Neurology 1996; 46: 16071612.
  • 20
    Wienshilboum RM,Sladek SL. Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32: 651662.
  • 21
    Relling MV,Yanishevski Y,Nemec J, et al. Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia. Leukemia 1998; 12: 346352.
  • 22
    Thomsen JB,Schroder H,Kristinsson J, et al. Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells. Relation to thiopurine metabolism. Cancer 1999; 86: 10801086.
  • 23
    Evans WE,Hon YY,Bomgaars L, et al. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol 2001; 19: 22932301.
  • 24
    Yates CR,Krynetski EY,Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997; 126: 608614.
  • 25
    Schaeffeler E,Fischer C,Brockmeier D, et al. Comprehensive analysis of thiopurine S-methyltransferase phenotype—genotype correlation in a large population of German Caucasians and identification of novel TPMT variants. Pharmacogenetics 2004; 14: 407417.